Characterisation of Neuropsychological and Motoric Performance in Patients With Hyponatremia
NCT ID: NCT01879774
Last Updated: 2022-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
189 participants
INTERVENTIONAL
2012-06-30
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physiology of Weakness in Movement Disorders
NCT00307346
EMG-Assessed Paratonia: A New Approach to Response Inhibition
NCT06573918
Investigation of Neurophysiological Functioning During Oral Comprehension Task
NCT06178276
Language in Primary Progressive Aphasia
NCT00537004
Disconnection and Unilateral Spatial Neglect
NCT05268159
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In terms of the question, if a therapeutic influence is also reasonable in slight symptomatic hyponatremia it is necessary to establish an accurate phenotyping of patients with hyponatremia, which quantifies the individual cognitive, motoric and psychological qualities.
Patients with hyponatremia will be examined on the basis of standardized neuropsychological and neurological tests. Following questions are to be answered with this study:
1. Which cognitive, motoric and psychological functions are impaired due to hyponatremia?
2. Is there a correlation between the extend of hyponatremia and the different test results?
3. Is there an intraindividual difference in test results during hyponatremia and normal sodium concentrations?
In addition to clinical testing, functional magnetic resonance imaging (fMRI) will be performed before and after therapy in up to 40 patients with hyponatremia. Functional magnetic resonance imaging (fMRI) is an imaging procedure in which local changes in cerebral oxygen concentration can be used to draw conclusions about brain activity. In connection with the current research project, an initial contribution is to be made in order to close the existing knowledge gap as to whether a functionally-image-morphologically tangible change in cerebral activity can also be depicted non-invasively by means of fMRI during hyponatremia or after its compensation. Another component of cerebral evaluation in this context is volumetry in fMRI.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with hyponatremia
Neuropsychological and motoric tests are conducted in patients with hyponatremia.
Neuropsychological and motoric tests
1. Neuropsychological tests
* Mini Mental Status Test
* Dem-Tect
* Rey-Osterrieth Complex Figure Test
* Trailmaking Test
* Beck Depression Inventory
* d2-R (optional)
2. Motoric tests
* modified UPDRS (Unified Parkinson Disease Rating Scale) Part III
* Timed-up-and-go Test
* Halstead Fingertapping Test
* AIMS (Abnormal involuntary movement scale)
3. EEG (only in patients with hyponatremia)
4. MRI (only in patients with hyponatremia)
Patients with normal serum sodium
Neuropsychological and motoric tests are conducted in patients with normal serum sodium.
Neuropsychological and motoric tests
1. Neuropsychological tests
* Mini Mental Status Test
* Dem-Tect
* Rey-Osterrieth Complex Figure Test
* Trailmaking Test
* Beck Depression Inventory
* d2-R (optional)
2. Motoric tests
* modified UPDRS (Unified Parkinson Disease Rating Scale) Part III
* Timed-up-and-go Test
* Halstead Fingertapping Test
* AIMS (Abnormal involuntary movement scale)
3. EEG (only in patients with hyponatremia)
4. MRI (only in patients with hyponatremia)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neuropsychological and motoric tests
1. Neuropsychological tests
* Mini Mental Status Test
* Dem-Tect
* Rey-Osterrieth Complex Figure Test
* Trailmaking Test
* Beck Depression Inventory
* d2-R (optional)
2. Motoric tests
* modified UPDRS (Unified Parkinson Disease Rating Scale) Part III
* Timed-up-and-go Test
* Halstead Fingertapping Test
* AIMS (Abnormal involuntary movement scale)
3. EEG (only in patients with hyponatremia)
4. MRI (only in patients with hyponatremia)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hyponatremia with serum sodium \< 130 mmol/l
* Men and women with normal serum sodium \> 130 mmol/l (control group)
Exclusion Criteria
* professional or private relationship between subject and the investigators, or dependance on the investigators
* Placement in an institution based on official orders
* Patients who are unable to give informed consent
* Patients with contraindication for MRI investigation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Cologne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Volker Burst
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Volker Burst, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Cologne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Cologne
Cologne, , Germany
Dipartimento di Scienze Biomediche, Sperimentali e Cliniche Mario Serio
Florence, , Italy
Hospital Universitario Clinico San Carlos
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.